Overview

An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the effectiveness and safety of acetaminophen extended release caplets and ibuprofen in relieving the muscle soreness that occurs after a marathon.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide
Treatments:
Acetaminophen
Ibuprofen
Criteria
Inclusion Criteria:

- Patients must complete the marathon

- be able to swallow the study medication

- comply with study requirements regarding the use of any other pain medications before,
during or after the marathon

- rate their muscle soreness on the evening after the marathon as at least a 4, on a
zero-to-ten point scale

- if female, must not be pregnant or breastfeeding, and must be using an acceptable form
of contraception

Exclusion Criteria:

- Previous diagnosis of osteoarthritis requiring pain medication therapy

- currently have a major medical illness

- have a history of cardiovascular disease, heat injury (heat exhaustion or heat stroke)
or collapse during a running or endurance event

- known hypersensitivity to acetaminophen or ibuprofen